Population pharmacokinetic modeling and simulation of fremanezumab in healthy subjects and patients with migraine

Population pharmacokinetic modeling and simulation of fremanezumab in healthy subjects and patients with migraine

Publication: Br J Clin Pharmacol

Fremanezumab is a fully humanized IgG2 Δa/κ monoclonal antibody specific for calcitonin gene-related peptide developed and approved for the

In Silico Molecular Docking Study of Delafloxacin against 4MQT for the Treatment of Acute Bacterial Skin and Skin Structure Infections

In Silico Molecular Docking Study of Delafloxacin against 4MQT for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Publication: Intl J Bioproc & Biotech Adv
Software: ADMET Predictor®

Infection occurring in the skin and its associated soft tissues such as loose connective tissue and mucous membranes is known as...

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Publication: Blood

Quizartinib is a once-daily, oral, highly potent and selective FLT3 inhibitor that has shown clinical activity in patients with relapsed/refractory acute myeloid leukemia (AML) with FLT3 internal tandem duplications in...

A novel series of chlorinated plastoquinone analogs: Design, synthesis, and evaluation of anticancer activity

A novel series of chlorinated plastoquinone analogs: Design, synthesis, and evaluation of anticancer activity

Publication: Chem Biol Drug Des
Software: ADMET Predictor®

Herein, we report the synthesis and cytotoxic effects of novel chlorinated plastoquinone analogs (ABQ1–17) against different leukemic cells.

Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments

Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments

Publication: Bioorg Chem
Software: ADMET Predictor®

This article briefs about the efforts taken to synthesis, characterize and develop (E)-5-methyl-2-phenyl-3-(thiophen-2-yl)-7-(thiophen-2-ylmethylene)..

Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms

Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms

Publication: Prostate

Background: Prostate cancer (PC) remains a leading cause of cancer mortality and the most successful chemopreventative and treatment strategies for PC come from targeting...

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media

Publication: Mol Ther Methods Clin Dev

Lentiviral vectors are increasingly utilized in cell and gene therapy applications because they efficiently transduce target cells such as hematopoietic stem cells and T cells. Large-scale production of current Good Manufacturing Practices-grade lentiviral vectors is limited because of the adherent, serum-dependent nature of HEK293T cells used in the manufacturing process.

Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies

Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies

Publication: J Pharm Sci
Software: GastroPlus®

Acid-reducing agents (ARAs) such as antacids, histamine-2 receptor antagonists, and proton pump inhibitors are widely prescribed in several disease states.

A practical approach to modeling the impact of amorphous drug nanoparticles on the oral absorption of poorly soluble drugs

A practical approach to modeling the impact of amorphous drug nanoparticles on the oral absorption of poorly soluble drugs

Authors: Stewart AM, Grass M
Publication: Mol Pharm
Software: GastroPlus®

Recently published studies have proposed that amorphous drug nanoparticles in gastrointestinal fluids may be beneficial for the absorption of poorly soluble compounds.

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

Publication: J Antimicrob Chemother

Animal models have suggested that the combination of pretomanid with pyrazinamide and moxifloxacin (PaMZ) may shorten TB therapy duration to 3–4 months.

Integrating In Vitro Testing and Physiologically-Based Pharmacokinetic (PBPK) Modelling for Chemical Liver Toxicity Assessment – a Case Study of Troglitazone

Integrating In Vitro Testing and Physiologically-Based Pharmacokinetic (PBPK) Modelling for Chemical Liver Toxicity Assessment – a Case Study of Troglitazone

Publication: Environ Toxicol Pharmacol
Software: GastroPlus®

In vitro to in vivo extrapolation (IVIVE) for next-generation risk assessment (NGRA) of chemicals requires computational modeling and faces unique challenges.